Made Scientific Expands Board for Cell Therapy Scale-Up
PRINCETON, New Jersey, April 30, 2026 Made Scientific, a U.S.-based cell therapy contract development and manufacturing organization (CDMO), announced...
Cell Therapy
Advertisement
Century Therapeutics Highlights CNTY-813 Data at ADA
PHILADELPHIA, Pennsylvania, April 2026 Century Therapeutics announced that its investigational program CNTY-813 has been selected for oral presentation at...
Thermo Fisher Opens US Bioprocess Center to Boost Biologics
WALTHAM, Massachusetts, USA, April 28, 2026 Thermo Fisher Scientific has announced the opening of its flagship U.S. Bioprocess Design...
Orca Bio Secures FDA RMAT Status for Orca-Q Therapy
MENLO PARK, Calif., April 28, 2026 Orca Bio has announced that the U.S. Food and Drug Administration (FDA) has...
Cellenkos Wins FDA Clearance for CK0801 Phase 2 Trial
HOUSTON, TEXAS, April 27, 2026 Cellenkos Inc. has received U.S. Food and Drug Administration (FDA) clearance to initiate a...
Advertisements
UCB Acquires Neurona to Advance Epilepsy Cell Therapy
BRUSSELS, Belgium, April 17, 2026 UCB, a global biopharmaceutical leader, has announced a definitive agreement to acquire Neurona Therapeutics...
Gilead Secures Approvals for Arcellx Acquisition Deal
FOSTER CITY, Calif., April 17, 2026 Gilead Sciences, Inc. has announced that it has obtained all required regulatory approvals...
Fate Therapeutics FT839 CAR T Shows Strong Preclinical Data
SAN DIEGO, Calif., April 16, 2026 Fate Therapeutics, Inc. has announced the presentation of preclinical data for its next-generation...
BioOra and Cincinnati Advance CAR-T Therapy in Leukemia
Wellington, New Zealand & Cincinnati, Ohio | April 13, 2026 BioOra Limited and Cincinnati Children’s Hospital Medical Center have...
Allogene Therapeutics Reports Strong ALPHA3 Trial Data
South San Francisco, California | April 13, 2026 Allogene Therapeutics has announced encouraging interim results from its pivotal Phase...
Advertisement
